Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura

被引:38
作者
McFarland, J [1 ]
机构
[1] Blood Ctr SE Wisconsin Inc, Platelet & Neutrophil Antibody Lab, Milwaukee, WI 53201 USA
关键词
D O I
10.1054/blre.2001.0169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mechanism of platelet destruction in immune (idiopathic) thrombocytopenic purpura (ITP) is thought to involve production of autoantibody to platelet surface antigens. Once coated with antibody, circulating platelets undergo sequestration via interaction with Fc receptors of macrophages in the reticuloendothelial system. A number of questions remain about the mechanism of platelet destruction in this disease: 1) What is the nature of the stimulus to the immune system that generates antiplatelet antibodies? 2) What is the role of interactions between T-helper lymphocytes and antigen-presenting cells in ITP? 3) What role, if any, is played by the targeting of single or multiple platelet surface glycoproteins by the autoimmune response? 4) Is the site of platelet destruction, intravascular or extravascular, or the state of activation of platelets important in the destruction of platelets? (C) 2002, Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1 / 2
页数:2
相关论文
共 21 条
[1]   MECHANISMS OF THROMBOCYTOPENIA IN CHRONIC AUTOIMMUNE THROMBOCYTOPENIC PURPURA - EVIDENCE OF BOTH IMPAIRED PLATELET PRODUCTION AND INCREASED PLATELET CLEARANCE [J].
BALLEM, PJ ;
SEGAL, GM ;
STRATTON, JR ;
GERNSHEIMER, T ;
ADAMSON, JW ;
SLICHTER, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01) :33-40
[2]   International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies [J].
Berchtold, P ;
Muller, D ;
Beardsley, D ;
Fujisawa, K ;
Kaplan, C ;
Kekomaki, R ;
Lipp, E ;
MorellKopp, MC ;
Kiefel, V ;
McMillan, R ;
vondemBorne, AEGK ;
Imbach, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (03) :477-483
[3]  
BERCHTOLD P, 1993, BLOOD, V81, P1246
[4]   Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura [J].
Bettaieb, A ;
Oksenhendler, E ;
Duedari, N ;
Bierling, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 103 (01) :19-23
[5]  
BETTAIEB A, 1992, BLOOD, V80, P162
[6]  
Cahill MR, 1998, BRIT J HAEMATOL, V100, P358
[7]  
DIXON R, 1975, NEW ENGL J MED, V292, P265
[8]  
FUJISAWA K, 1993, BLOOD, V81, P2872
[9]   Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology [J].
George, JN ;
Woolf, SH ;
Raskob, GE ;
Wasser, JS ;
Aledort, LM ;
Ballem, PJ ;
Blanchette, VS ;
Bussel, JB ;
Cines, DB ;
Kelton, JG ;
Lichtin, AE ;
McMillan, R ;
Okerbloom, JA ;
Regan, DH ;
Warrier, I .
BLOOD, 1996, 88 (01) :3-40
[10]  
GEORGE JN, 1996, THROMBOCYTOPENIA DUE, P1315